Ubiquitin focused drug discovery
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D
Click on the link below to download our brochure detailing “The Unbiquitin System” and how “The analogous ubiquitin cell signalling system is the next big opportunity beyond kinases representing greater therapeutic reach.”
To find out more information about Integrated Drug Discovery read more
If you’re interested in exploring how you can access the DUBtarget-001 DUB targeted library please Contact us directly.